Sort   by:  
 Page size 
UnknownHuman Papillomavirus-Associated Oropharyngeal Cancer: Defining Risk Groups and Clinical Trials.
Not available
S-EPMC5814107 | biostudies-literature
UnknownPhase III randomized, placebo-controlled trial of docetaxel with or without gefitinib in recurrent or metastatic head and neck cancer: an eastern cooperative oncology group trial.
Not available
S-EPMC3612594 | biostudies-literature
UnknownAurora kinases in head and neck cancer.
Not available
S-EPMC4139969 | biostudies-literature
UnknownA phase II study of capecitabine, oxaliplatin, and cetuximab with or without bevacizumab as frontline therapy for metastatic colorectal cancer. A Fox Chase extramural research study.
Not available
S-EPMC3400721 | biostudies-literature
UnknownNovel Molecular Targets for Chemoprevention in Malignancies of the Head and Neck.
Not available
S-EPMC5615328 | biostudies-literature
UnknownOropharyngeal squamous cell carcinoma treatment: current standards and future directions.
Not available
S-EPMC5813288 | biostudies-literature
UnknownE1308: Phase II Trial of Induction Chemotherapy Followed by Reduced-Dose Radiation and Weekly Cetuximab in Patients With HPV-Associated Resectable Squamous Cell Carcinoma of the Oropharynx- ECOG-ACRIN Cancer Research Group.
Not available
S-EPMC5455313 | biostudies-literature
UnknownTreatment de-intensification strategies for head and neck cancer.
Not available
S-EPMC5734050 | biostudies-literature
UnknownImmunotherapy for head and neck cancer: Recent advances and future directions.
Not available
S-EPMC7749717 | biostudies-literature
UnknownPaclitaxel With or Without Cixutumumab as Second-Line Treatment of Metastatic Esophageal or Gastroesophageal Junction Cancer: A Randomized Phase II ECOG-ACRIN Trial.
Not available
S-EPMC10485278 | biostudies-literature
Sort   by:  
 Page size